U
Umberto Vitolo
Researcher at University of Turin
Publications - 426
Citations - 17692
Umberto Vitolo is an academic researcher from University of Turin. The author has contributed to research in topics: Diffuse large B-cell lymphoma & Rituximab. The author has an hindex of 63, co-authored 402 publications receiving 15366 citations. Previous affiliations of Umberto Vitolo include Mayo Clinic & Peter MacCallum Cancer Centre.
Papers
More filters
Journal ArticleDOI
Follicular lymphoma international prognostic index.
Philippe Solal-Celigny,Pascal Roy,Philippe Colombat,J. M. White,James Olen Armitage,Reyes Arranz-Saez,Wing Yan Au,Monica Bellei,Pauline Brice,Dolores Caballero,Bertrand Coiffier,Eulogio Conde-Garcia,Chantal Doyen,Massimo Federico,Richard I. Fisher,Javier García-Conde,Cesare Guglielmi,Anton Hagenbeek,Corinne Haioun,Michael LeBlanc,Andrew Lister,Armando López-Guillermo,Peter McLaughlin,Noel Milpied,Pierre Morel,Nicolas Mounier,Stephen J. Proctor,Ama Z. S. Rohatiner,Paul Smith,Pierre Soubeyran,Hervé Tilly,Umberto Vitolo,Pier Luigi Zinzani,Emanuele Zucca,Emili Montserrat +34 more
TL;DR: The Follicular Lymphoma International Prognostic Index was designed from the data recorded over 8 years of nearly 5000 patients registered worldwide to help provide an optimal treatment option for patients with follicular lymphoma.
Journal ArticleDOI
Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
Andrea Gallamini,Martin Hutchings,Luigi Rigacci,Lena Specht,Francesco Merli,Mads Hansen,Caterina Patti,Annika Loft,Francesco Di Raimondo,Francesco d'Amore,Alberto Biggi,Umberto Vitolo,Caterina Stelitano,R Sancetta,Livio Trentin,Stefano Luminari,Emilio Iannitto,Simonetta Viviani,Ivana Pierri,Alessandro Levis +19 more
TL;DR: PET-2 overshadows the prognostic value of IPS and emerges as the single most important tool for planning of risk-adapted treatment in advanced HL.
Journal ArticleDOI
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hervé Tilly,M. Gomes da Silva,Umberto Vitolo,Andrew Jack,Michel Meignan,Armando López-Guillermo,Jan Walewski,Marc André,Peter Johnson,Michael Pfreundschuh,Marco Ladetto +10 more
TL;DR: This work presents the results of a double-blind, placebo-controlled study conducted at the University of Southampton over a two-week period in June and July of last year that demonstrated clear trends in prognosis for breast cancer in smokers and women with a history of smoking.
Journal ArticleDOI
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Massimo Federico,Monica Bellei,Luigi Marcheselli,Stefano Luminari,Armando López-Guillermo,Umberto Vitolo,Barbara Pro,Stefano Pileri,Alessandro Pulsoni,Pierre Soubeyran,Sergio Cortelazzo,Giovanni Martinelli,Maurizio Martelli,Luigi Rigacci,Luca Arcaini,Francesco Di Raimondo,Francesco Merli,Elena Sabattini,Peter McLaughlin,Philippe Solal-Celigny +19 more
TL;DR: Follicular Lymphoma International Prognostic Index 2 is a simple prognostic index based on easily available clinical data and may represent a promising new tool for the identification of patients with FL at different risk in the era of immunochemotherapy.
Journal ArticleDOI
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
TL;DR: This work presents a meta-analysis of 120 cases of central giant cell granuloma in mice over a 12-month period and shows clear trends in survival and morbidity during the first year of treatment with chemotherapy.